EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy
James Kang, Albert I. Ko, Sang Hoon Kil, Jon Mallen‐St. Clair, Daniel Sanghoon Shin, Marilene B. Wang, Eri S. Srivatsan
Topics & Concepts
CetuximabEpidermal growth factor receptorImmunotherapyMedicineCancer researchReceptor tyrosine kinaseMonoclonal antibodyEGFR inhibitorsMAPK/ERK pathwayTyrosine kinasePI3K/AKT/mTOR pathwayImmune systemSignal transductionReceptorImmunologyInternal medicineAntibodyBiologyCell biologyLung Cancer Treatments and MutationsHER2/EGFR in Cancer ResearchCancer Immunotherapy and Biomarkers